PRCT
PROCEPT BioRobotics CorpTrades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-09 | Garrett Mary |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Common Stock
|
3,315 |
| 2026-06-09 | MOLL FREDERIC H |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Common Stock
|
3,315 |
| 2026-06-09 | Little Elisabeth Sandoval |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option (Right to Buy)
|
5,853 |
| 2026-06-09 | PRESCOTT THOMAS M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Common Stock
|
3,315 |
| 2026-06-09 | PUCKETT DAN |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option (Right to Buy)
|
5,853 |
| 2026-06-09 | Desai Antal Rohit |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option (Right to Buy)
|
5,853 |
| 2026-06-09 | Desai Antal Rohit |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Common Stock
|
3,315 |
| 2026-06-09 | Harris Taylor C. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option (Right to Buy)
|
5,853 |
| 2026-06-09 | Garrett Mary |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option (Right to Buy)
|
5,853 |
| 2026-06-09 | MOLL FREDERIC H |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option (Right to Buy)
|
5,853 |
| 2026-06-09 | Little Elisabeth Sandoval |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Common Stock
|
3,315 |
| 2026-06-09 | PUCKETT DAN |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Common Stock
|
3,315 |
| 2026-06-09 | Harris Taylor C. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Common Stock
|
3,315 |
| 2026-06-09 | Dodrill Amy M. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Common Stock
|
3,315 |
| 2026-06-09 | PRESCOTT THOMAS M |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option (Right to Buy)
|
5,853 |
| 2026-06-09 | Dodrill Amy M. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. |
Stock Option (Right to Buy)
|
5,853 |
| 2026-06-08 | Templin Barry L |
EVP, Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on June 5, 2026. Includes 860 shares acquired on May 14, 2026, under the Issuer's 2021 Employee Stock Purchase Plan. |
Common Stock
|
358 |
| 2026-06-08 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on June 5, 2026. |
Common Stock
|
285 |
| 2026-06-08 | Waters Kevin |
EVP, CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on June 5, 2026. |
Common Stock
|
357 |
| 2026-03-19 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Sell↓
Filing footnotes — Common Stock (Direct)
The stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.025 to $26.020, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
3,031 |
| 2026-03-19 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Sell↓
Filing footnotes — Common Stock (Direct)
The stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.025 to $26.450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
2,332 |
| 2026-03-17 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. |
Common Stock
|
304 |
| 2026-03-17 | Waters Kevin |
EVP, CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. |
Common Stock
|
706 |
| 2026-03-10 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.365 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
145 |
| 2026-03-10 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.11 to $25.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
3,098 |
| 2026-03-09 | Desai Antal Rohit |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.40 to $24.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
43,581 |
| 2026-03-09 | Desai Antal Rohit |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.40 to $25.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
53,818 |
| 2026-03-09 | Desai Antal Rohit |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.40 to $25.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
1,300 |
| 2026-03-06 | Desai Antal Rohit |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.79 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
53,763 |
| 2026-03-06 | Desai Antal Rohit |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.785 to $23.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
106,554 |
| 2026-03-06 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units and Performance Stock Units. |
Common Stock
|
6,892 |
| 2026-03-06 | Waters Kevin |
EVP, CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units and Performance Stock Units. |
Common Stock
|
6,721 |
| 2026-03-05 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. |
Stock Option (Right to Buy)
|
29,615 |
| 2026-03-05 | PUCKETT DAN |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-05 | Desai Antal Rohit |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.10 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
24,748 |
| 2026-03-05 | Wood Larry L |
Global President TAVR & Surg |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. |
Stock Option (Right to Buy)
|
103,653 |
| 2026-03-05 | Waters Kevin |
EVP, CFO |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. |
Common Stock
|
47,462 |
| 2026-03-05 | PUCKETT DAN |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-third of the RSUs shall vest on March 5, 2027, with one-third of the remaining RSUs vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date. |
Common Stock
|
5,476 |
| 2026-03-05 | Waters Kevin |
EVP, CFO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. |
Stock Option (Right to Buy)
|
32,576 |
| 2026-03-05 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. |
Common Stock
|
43,811 |
| 2026-03-05 | Desai Antal Rohit |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.0645 to $26.0213, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
142,498 |
| 2026-03-05 | PUCKETT DAN |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This Stock Option was granted on March 5, 2026, and one-third of the shares subject to the Stock Option shall vest on March 5, 2027, with one-third of the remaining shares subject to the Stock Option vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date. |
Stock Option (Right to Buy)
|
8,897 |
| 2026-03-05 | Wood Larry L |
Global President TAVR & Surg |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. |
Common Stock
|
127,783 |
| 2026-02-19 | Waters Kevin |
EVP, CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock. |
Common Stock
|
3,532 |
| 2026-02-19 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock. |
Common Stock
|
4,872 |
| 2025-09-02 | Wood Larry L |
Global President TAVR & Surg |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock Option was granted on September 2, 2025 and one-quarter of the shares subject to the Stock Option will vest on September 2, 2026, and the remainder shall vest monthly thereafter at the rate of 1/48th of the original number of shares subject to the Stock Option, subject to the Reporting Person continuing as a service provider through such date. |
Stock Option (Right to Buy)
|
319,618 |
| 2025-09-02 | Wood Larry L |
Global President TAVR & Surg |
Award↑
Filing footnotes — Common Stock (Direct)
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on September 2, 2026, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date. The ending balance was adjusted to reflect the forfeiture (for no consideration) of 2,765 unvested RSUs previously granted to the Reporting Person in April 2024 and June 2025 under the issuer's non-employee director compensation program. |
Common Stock
|
182,392 |
| 2025-08-14 | Desai Antal Rohit |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Transaction is a cash exercise by the reporting person. The option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
26,749 |
| 2025-08-14 | Desai Antal Rohit |
Director |
Convert↑
|
Common Stock
|
26,749 |
| 2025-08-14 | Nouri Alaleh |
EVP, CLO, CORP. SEC. |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Transaction is a cash exercise by the reporting person. The option is fully vested and exercisable. |
Stock Option (Right to Buy)
|
11,000 |